These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 2297760

  • 1. A latent Mr 94,000 gelatin-degrading metalloprotease induced during differentiation of HL-60 promyelocytic leukemia cells: a member of the collagenase family of enzymes.
    Davis GE, Martin BM.
    Cancer Res; 1990 Feb 15; 50(4):1113-20. PubMed ID: 2297760
    [Abstract] [Full Text] [Related]

  • 2. Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells.
    Moll UM, Youngleib GL, Rosinski KB, Quigley JP.
    Cancer Res; 1990 Oct 01; 50(19):6162-70. PubMed ID: 2169335
    [Abstract] [Full Text] [Related]

  • 3. Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines.
    Brown PD, Levy AT, Margulies IM, Liotta LA, Stetler-Stevenson WG.
    Cancer Res; 1990 Oct 01; 50(19):6184-91. PubMed ID: 2169338
    [Abstract] [Full Text] [Related]

  • 4. Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs).
    Dittmann KH, Lottspeich F, Ries C, Petrides PE.
    Exp Hematol; 1995 Feb 01; 23(2):155-60. PubMed ID: 7828672
    [Abstract] [Full Text] [Related]

  • 5. Production and activation of matrix metalloprotease-9 (MMP-9) by HL-60 promyelocytic leukemia cells.
    Devy L, Noël A, Baramova E, Bajou K, Trentesaux C, Jardillier JC, Foidart JM, Jeannesson P.
    Biochem Biophys Res Commun; 1997 Sep 29; 238(3):842-6. PubMed ID: 9325178
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Purification and characterization of extracellular matrix-degrading metalloproteinase, matrin (pump-1), secreted from human rectal carcinoma cell line.
    Miyazaki K, Hattori Y, Umenishi F, Yasumitsu H, Umeda M.
    Cancer Res; 1990 Dec 15; 50(24):7758-64. PubMed ID: 2253219
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of phorbol ester treatment on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells.
    Zwelling LA, Chan D, Hinds M, Mayes J, Silberman LE, Blick M.
    Cancer Res; 1988 Dec 01; 48(23):6625-33. PubMed ID: 2846155
    [Abstract] [Full Text] [Related]

  • 11. Novobiocin- and phorbol-12-myristate-13-acetate-induced differentiation of human leukemia cells associated with a reduction in topoisomerase II activity.
    Constantinou A, Henning-Chubb C, Huberman E.
    Cancer Res; 1989 Mar 01; 49(5):1110-7. PubMed ID: 2537141
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Purified staphylococcal culture medium stimulates neutral metalloprotease secretion from human articular cartilage.
    Williams RJ, Smith RL, Schurman DJ.
    J Orthop Res; 1991 Mar 01; 9(2):258-65. PubMed ID: 1846914
    [Abstract] [Full Text] [Related]

  • 14. Induction of transforming growth factor beta 1 and its receptor expression during myeloid leukemia cell differentiation.
    Taipale J, Matikainen S, Hurme M, Keski-Oja J.
    Cell Growth Differ; 1994 Dec 01; 5(12):1309-19. PubMed ID: 7696179
    [Abstract] [Full Text] [Related]

  • 15. Expression of selected genes and oncogenes in differentiated HL-60 cells and primary cells from human leukemias.
    Shiosaka T, Tanaka Y.
    Anticancer Res; 1989 Dec 01; 9(5):1249-64. PubMed ID: 2589822
    [Abstract] [Full Text] [Related]

  • 16. Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate.
    Murao S, Gemmell MA, Callaham MF, Anderson NL, Huberman E.
    Cancer Res; 1983 Oct 01; 43(10):4989-96. PubMed ID: 6576856
    [Abstract] [Full Text] [Related]

  • 17. Studies on the effects of laminin, E-8 fragment of laminin and synthetic laminin peptides PA22-2 and YIGSR on matrix metalloproteinases and tissue inhibitor of metalloproteinase expression.
    Mackay AR, Gomez DE, Nason AM, Thorgeirsson UP.
    Lab Invest; 1994 Jun 01; 70(6):800-6. PubMed ID: 8015284
    [Abstract] [Full Text] [Related]

  • 18. Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells.
    Nakajima M, Lotan D, Baig MM, Carralero RM, Wood WR, Hendrix MJ, Lotan R.
    Cancer Res; 1989 Apr 01; 49(7):1698-706. PubMed ID: 2538232
    [Abstract] [Full Text] [Related]

  • 19. Prostaglandins E2 and E1 inhibit cytokine-induced metalloprotease expression in human synovial fibroblasts. Mediation by cyclic-AMP signalling pathway.
    DiBattista JA, Martel-Pelletier J, Fujimoto N, Obata K, Zafarullah M, Pelletier JP.
    Lab Invest; 1994 Aug 01; 71(2):270-8. PubMed ID: 8078306
    [Abstract] [Full Text] [Related]

  • 20. Topoisomerase II alpha promoter trans-activation early in monocytic differentiation of HL-60 human leukemia cells.
    Fraser DJ, Brandt TL, Kroll DJ.
    Mol Pharmacol; 1995 Apr 01; 47(4):696-706. PubMed ID: 7723730
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.